The observed reduced response to IL-2 in the CD25hi cells of the MS and T1D cohorts, was not due to the percentage of subjects carrying the risk allele (control 59%, T1D 50% MS 64% A/A genotype: p = 0.1393, chi-square test Table I). This evidence concerns the gene IL2 and type 1 diabetes mellitus.